Company Filing History:
1 out of 15 
1 out of 1 
1 out of 1 Years Active: 1993-2013
Title: Bernd Schneider: Innovator in Pharmaceutical Composition
Introduction
Bernd Schneider is a notable inventor based in Iserlohn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating various medical conditions. With a total of 3 patents to his name, Schneider's work has the potential to impact the lives of many individuals suffering from disorders such as ADHD and narcolepsy.
Latest Patents
One of Schneider's latest patents is a psychostimulant containing pharmaceutical composition. This invention focuses on a formulation that includes an enteric coating, allowing for a sustained release of the psychostimulant in vivo. The composition is designed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and its comorbidities, as well as conditions like narcolepsy, fatigue, and cognitive decline associated with systemic diseases such as acquired immunodeficiency syndrome and oncological diseases. Additionally, Schneider has developed a process for preparing optically active 2-aryl-alkanoic acids, which involves a chemical process for the preparation of a pharmaceutically active compound in stereospecific form.
Career Highlights
Throughout his career, Bernd Schneider has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Medice Chem.-pharm. Fabrik Putter GmbH & Co. KG and Medice, Ltd. These experiences have allowed him to refine his expertise and contribute to innovative solutions in the field.
Collaborations
Schneider has collaborated with esteemed colleagues such as Henrich H. Paradies and Samir B. Hanna. These partnerships have likely enriched his work and fostered advancements in pharmaceutical research.
Conclusion
In summary, Bernd Schneider is a distinguished inventor whose work in pharmaceutical compositions has the potential to address critical health issues. His innovative patents and collaborations reflect his commitment to improving medical treatments and enhancing patient care.